Analyst Activity – Royal Bank of Canada Lowers Its Price Target On NASDAQ:AMGN – Amgen (NASDAQ:AMGN) to

ME Staff
-
0

Analyst Ratings For NASDAQ:AMGN – Amgen (NASDAQ:AMGN)

Today, Royal Bank of Canada lowered its price target on NASDAQ:AMGN – Amgen (NASDAQ:AMGN) to per share.

Some recent analyst ratings include

  • 4/24/2018-Cowen Reiterated Rating of Buy.
  • 2/5/2018-Atlantic Securities was Downgraded by analysts at Atlantic Securities from a “Overweight ” rating to a ” Neutral” rating. They now have a $187.01 price target on the stock.
  • 2/4/2018-JPMorgan Chase Reiterated Rating of Hold.
  • 2/2/2018-Leerink Swann Reiterated Rating of Market Perform.

Dividend information for NASDAQ:AMGN – Amgen (NASDAQ:AMGN)

NASDAQ:AMGN – Amgen (NASDAQ:AMGN) pays an annual dividend of $5.28 with a yield of 3.06% and an average dividend growth of 23.50% based on a 3 Year Average..

Dividend History for NASDAQ:AMGN – Amgen (NASDAQ:AMGN)

  • On 3/7/2018 NASDAQ:AMGN – Amgen announced a quarterly dividend of $1.32 2.81554951207807% with an ex dividend date of 5/16/2018 which will be payable on 6/8/2018.
  • On 12/12/2017 NASDAQ:AMGN – Amgen announced a quarterly dividend of $1.32 2.98% with an ex dividend date of 2/14/2018 which will be payable on 3/8/2018.
  • On 10/24/2017 NASDAQ:AMGN – Amgen announced a quarterly dividend of $1.15 2.59% with an ex dividend date of 11/16/2017 which will be payable on 12/8/2017.
  • On 7/28/2017 NASDAQ:AMGN – Amgen announced a quarterly dividend of $1.15 2.64% with an ex dividend date of 8/15/2017 which will be payable on 9/8/2017.
  • On 3/7/2017 NASDAQ:AMGN – Amgen announced a quarterly dividend of $1.15 2.59% with an ex dividend date of 5/15/2017 which will be payable on 6/8/2017.
  • On 12/20/2016 NASDAQ:AMGN – Amgen announced a quarterly dividend of $1.15 3.15% with an ex dividend date of 2/13/2017 which will be payable on 3/8/2017.
  • On 10/14/2016 NASDAQ:AMGN – Amgen announced a quarterly dividend of $1.00 2.46% with an ex dividend date of 11/14/2016 which will be payable on 12/8/2016.

Recent Insider Trading Activity For NASDAQ:AMGN – Amgen (NASDAQ:AMGN)
NASDAQ:AMGN – Amgen (NASDAQ:AMGN) has insider ownership of 0.27% and institutional ownership of 85.76%.

  • On 4/12/2018 Sean E. Harper, EVP, sold 1,525 with an average share price of $172.68 per share and the total transaction amounting to $263,337.00.
  • On 3/16/2018 Sean E. Harper, EVP, sold 1,525 with an average share price of $189.75 per share and the total transaction amounting to $289,368.75.
  • On 2/14/2018 Sean E. Harper, EVP, sold 1,525 with an average share price of $174.18 per share and the total transaction amounting to $265,624.50.
  • On 1/16/2018 Sean E. Harper, EVP, sold 1,525 with an average share price of $185.62 per share and the total transaction amounting to $283,070.50.
  • On 12/12/2017 Sean E Harper, EVP, sold 1,525 with an average share price of $176.83 per share and the total transaction amounting to $269,665.75.
  • On 11/13/2017 Sean E Harper, EVP, sold 1,525 with an average share price of $171.58 per share and the total transaction amounting to $261,659.50.
  • On 11/8/2017 Carbonnel Francois De, Director, sold 4,000 with an average share price of $173.61 per share and the total transaction amounting to $694,440.00.

Recent Trading Activity for NASDAQ:AMGN – Amgen (NASDAQ:AMGN)
Shares of NASDAQ:AMGN – Amgen closed the previous trading session at 171.37 down -0.57 0.33% with shares trading hands.